A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
From Downtime to Data: Rethinking Restroom Reliability in Healthcare
LeChase Building Four-Story Addition to UHS Delaware Valley Hospital
AdventHealth Sebring Breaks Ground on Expansion Project
Regulations Take the Lead in Healthcare Restroom Design
AHN Allegheny Valley Hospital Opens Expanded Inpatient Rehabilitation Unit